UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting

European journal of nuclear medicine and molecular imaging, 2023-11, Vol.50 (13), p.3851-3861

2023

Volltextzugriff (PDF)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

Reviews in endocrine & metabolic disorders, 2021-09, Vol.22 (3), p.495-510

2021

Volltextzugriff (PDF)

Review: Receptor Targeted Nuclear Imaging of Breast Cancer

International journal of molecular sciences, 2017-01, Vol.18 (2), p.260-260

2017

Volltextzugriff (PDF)

Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

European journal of nuclear medicine and molecular imaging, 2022-11, Vol.49 (13), p.4616-4641

2022

Volltextzugriff (PDF)

Therapeutic Applications of Pretargeting

Pharmaceutics, 2019-09, Vol.11 (9), p.434

2019

Volltextzugriff (PDF)

Radiolabeled Bombesin Analogs

Cancers, 2021-11, Vol.13 (22), p.5766

2021

Volltextzugriff (PDF)

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy

Cancers, 2021-03, Vol.13 (5), p.1100

2021

Volltextzugriff (PDF)

Progressive APOBEC3B mRNA expression in distant breast cancer metastases

PloS one, 2017-01, Vol.12 (1), p.e0171343

2017

Volltextzugriff (PDF)

Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer

Pharmaceutics, 2022-01, Vol.14 (1), p.195

2022

Volltextzugriff (PDF)

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer

Pharmaceutics, 2021-05, Vol.13 (5), p.674

2021

Volltextzugriff (PDF)

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2021-05, Vol.48 (5), p.1339-1350

2021

Volltextzugriff (PDF)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

Frontiers in oncology, 2023-08, Vol.13, p.1199432-1199432

2023

Volltextzugriff (PDF)

Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity

European journal of nuclear medicine and molecular imaging, 2022-11, Vol.49 (13), p.4440-4451

2022

Volltextzugriff (PDF)

Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer

Pharmaceuticals (Basel, Switzerland), 2023-07, Vol.16 (8), p.1072

2023

Volltextzugriff (PDF)

In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer

Journal of Nuclear Medicine, 2015-05, Vol.56 (5), p.752-757

2015

Volltextzugriff (PDF)

Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells

Cancers, 2021-09, Vol.13 (19), p.4905

2021

Volltextzugriff (PDF)

Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging

Cancers, 2023-04, Vol.15 (7), p.2161

2023

Volltextzugriff (PDF)

DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells

PloS one, 2013-04, Vol.8 (4), p.e61555

2013

Volltextzugriff (PDF)

Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy

Journal of Nuclear Medicine, 2015-10, Vol.56 (10), p.1487-1493

2015

Volltextzugriff (PDF)

The Balance Between the Therapeutic Efficacy and Safety of [177Lu]Lu-NeoB in a Preclinical Prostate Cancer Model

Molecular imaging and biology, 2024-02, Vol.26 (1), p.114-123

2024

Volltextzugriff (PDF)

Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice

Life sciences (1973), 2023-12, Vol.334, p.122173-122173, Article 122173

2023

Volltextzugriff (PDF)

The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo

Pharmaceutics, 2022-01, Vol.14 (1), p.173

2022

Volltextzugriff (PDF)

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

PloS one, 2017-01, Vol.12 (1), p.e0170536-e0170536

2017

Volltextzugriff (PDF)

Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors

Frontiers in endocrinology (Lausanne), 2023-05, Vol.14, p.1184436-1184436

2023

Volltextzugriff (PDF)

SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?

Journal of Nuclear Medicine, 2017-10, Vol.58 (10), p.1609-1614

2017

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(45)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(29)
Tumors
(17)
Humans
(16)
Breast Cancer
(14)
Nuclear Medicine
(13)
Oncology
(13)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Prostate Cancer
(12)
Imaging
(11)
Medicine
(11)
Animals
(10)
Medicine & Public Health
(10)
Mice
(10)
Radiology
(10)
Pharmacology & Pharmacy
(9)
Cancer
(8)
Cell Line, Tumor
(8)
Female
(8)
Gastrin
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

Review: Receptor Targeted Nuclear Imaging of Breast Cancer

Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

Therapeutic Applications of Pretargeting

Radiolabeled Bombesin Analogs

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy

Progressive APOBEC3B mRNA expression in distant breast cancer metastases

Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity

Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer

In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer

Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells

Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging

DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells

Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy

The Balance Between the Therapeutic Efficacy and Safety of [177Lu]Lu-NeoB in a Preclinical Prostate Cancer Model

Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice

The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors

SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?

Suchergebnisse filtern